Evidence is inconsistent regarding the impact of late gestational diabetes mellitus (GDM) on perinatal outcomes.
To evaluate associations of GDM diagnosed in the third trimester (late GDM) with adverse obstetric and neonatal outcomes.
We searched Embase, Medline, and Web of Science from January 1, 1990 to June 16, 2022, for observational studies.
Late GDM was defined as a de novo diagnosis, i.e. after a negative screening for diabetes in the second trimester, and at later than 28 weeks of pregnancy.
Each abstract and full‐text article was independently reviewed by the same two authors. Quality was assessed with the use of the Newcastle‐Ottawa Scale. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random effects model.
Twelve studies were identified as meeting the inclusion criteria, including 3103 patients (571 with late GDM and 3103 controls). Incidences of shoulder dystocia (OR 1.57, 95% CI 1.02–2.42, P = 0.040), 5‐minute Apgar score <7 (OR 1.80, 95% CI 1.14–2.86, P = 0.024), cesarean delivery (OR 1.98, 95% CI 1.51–2.60, P < 0.001), and emergent cesarean delivery (OR 1.57, 95% CI 1.02–2.40, P = 0.040) were significantly higher among women with late GDM than among the controls. The groups showed similarity in the rates of fetal macrosomia, large‐for‐gestational‐age fetuses, neonatal hypoglycemia, and hypertensive disorders of pregnancy.
Late gestational diabetes mellitus, diagnosed after 32 weeks, was associated with higher incidence of shoulder dystocia, 5‐minute Apgar score <7 and cesarean delivery.
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.